Chabiotech Co

Chabiotech Co Current Assets

The Current Assets of Chabiotech Co (085660.KQ) as of Nov 1, 2026 is 62.47 B KRW. In the previous year, Current Assets was 706.58 B KRW — a change of -91.16% (lower).

Current Assets

62.47 BKRW

YoY

-91.16%

Last updated:

Current Assets of Chabiotech Co is 2025 62.47 B KRW. Current Assets of Chabiotech Co was 2024 706.58 B KRW. It decreases by -91.16% lower compared to the previous year.

The Chabiotech Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
455.74 B KRW
Jan 1, 2019
496.39 B KRW
Jan 1, 2020
558.45 B KRW
Jan 1, 2021
543.35 B KRW
Jan 1, 2022
495.40 B KRW
Jan 1, 2023
491.78 B KRW
Jan 1, 2024
706.58 B KRW
Jan 1, 2025
62.47 B KRW
The Chabiotech Co Current Assets history
YEARCurrent AssetsYoY
62.47 BKRW-91.16%
706.58 BKRW+43.68%
491.78 BKRW-0.73%
495.40 BKRW-8.82%
543.35 BKRW-2.70%
558.45 BKRW+12.50%
496.39 BKRW+8.92%
455.74 BKRW-0.45%
457.81 BKRW+0.46%
455.71 BKRW+27.10%
358.55 BKRW+145.12%
146.28 BKRW+22.35%
119.55 BKRW-10.03%
132.88 BKRW+6.49%
124.78 BKRW+21.94%
102.33 BKRW+33.10%
76.88 BKRW+117.94%
35.28 BKRW-1.17%
35.70 BKRW+72.79%
20.66 BKRW-9.71%
22.88 BKRW+182.14%
8.11 BKRW+505.60%
1.34 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Chabiotech Co Stock analysis

What does Chabiotech Co do? Cha Biotech Co., Ltd. generates revenue through its bio segment, which provides medical services, develops stem cell and cell therapy products, produces cosmetics and cosmetic raw materials, distributes medical devices, and offers cord blood storage and health care services. The optical segment manufactures optical lenses, optical modules, and other parts for mobile phone cameras. The company serves healthcare providers, medical device distributors, and consumers seeking cosmetic and health services. Its bio segment targets medical and wellness markets, while the optical segment caters to mobile phone manufacturers and component suppliers. The company's products include stem cell therapy solutions, cosmetic raw materials, medical devices, and optical components. It operates through two main segments: bio and optical, with the bio segment focusing on healthcare and wellness services, and the optical segment on manufacturing optical parts for mobile devices. The bio segment's cord blood storage services are a key offering for health-conscious consumers, while the optical segment supplies components to mobile phone camera manufacturers. Cha Biotech's revenue streams come from medical service provision, product development in cell therapy, cosmetic production, medical device distribution, cord blood storage, and optical component manufacturing. The company serves healthcare institutions, cosmetic brands, medical device companies, and mobile phone manufacturers. Its bio segment's health care services and optical segment's mobile phone camera parts are central to its business model. Chabiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Chabiotech Co stock

Current Assets of Chabiotech Co is 62.47 B KRW in 2025.

Current Assets of Chabiotech Co changed from 706.58 B KRW to 62.47 B KRW, representing a -91.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Chabiotech Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Chabiotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Chabiotech Co

All Key Metrics — Chabiotech Co